SMA®T Arthritis is a new patented marketing tool designed to significantly increase repeat sales of NSAIDs (i.e. ibuprofen, naproxen, diclofenac etc.) to people with knee arthritis.
SMA®T Arthritis encourages a customer to proactively and more intensively use NSAID remedies in order to avoid subjective pain sensation variations. It improves brand loyalty and will allow a pharma that acquires a pool of intellectual property (IP) to
• Stand out from a crowd of competitors with a unique value proposition.
• Constantly promote NSAID brand via a proactive message “Prevent your pain” or “Prevent your knee joint damage”.
• Reach sustainable growth of repeat sales through brand loyalty.
• Win competition over manufacturers selling 2% or 3% ointments as your customer will repeatedly apply a remedy motivated by a “red spot” elimination on his knee.
• Promote NSAID bundled with SMA®T Arthritis as the only smart way to treat arthritis.
• Give arthritic patients an opportunity to monitor the effectiveness of NSAID.
Company’s Keywords:
medical devices, knee arthritis, nsaid, disease management, pain management, intellectual property management
0
medical devices
2014
Your request has been submitted successfully.
Own or work here?